This Article Full Text Full Text (PDF) All Versions of this Article: 106/20/2588    most recent 01.CIR.0000036082.04708.83v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Borgdorff, P. Articles by Tangelder, G. J. Search for Related Content PubMed PubMed Citation Articles by Borgdorff, P. Articles by Tangelder, G. J. Related Collections Secretion Aggregation CV surgery: other Platelets Endothelium/vascular type/nitric oxide Other Vascular biology

(Circulation. 2002;106:2588.)
© 2002 American Heart Association, Inc.

Basic Science Reports

Hypotension Caused by Extracorporeal Circulation

Serotonin From Pump-Activated Platelets Triggers Nitric Oxide Release

From the Laboratory for Physiology, Institute for Cardiovascular Research, Vrije Universiteit Medical Center, Amsterdam (P.B., G.J.T.), and the Department of Psychiatry, Erasmus University, Rotterdam (D.F.), The Netherlands.

Reprint requests to P. Borgdorff, PhD, Laboratory for Physiology, VUMC, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. E-mail p.borgdorff.physiol{at}med.vu.nl

Background— Cardiopulmonary bypass and hemodialysis often cause hypotension. We investigated a possible role of pump-induced platelet activation with consequent serotonin release.

Methods and Results— In rats, a heparin-coated extracorporeal shunt was placed between the proximal part of a carotid artery and the distal part of a femoral artery. Autoperfusion did not affect platelets or hemodynamics. Pump perfusion, however, immediately elicited strong platelet aggregation, whereas aortic pressure rapidly fell to 60±12% (mean±SD) of its prepump value, partially recovered, and then progressively decreased to 70±12% at 2 hours. Femoral resistance doubled and then decreased to 59±11%. The initial changes in aortic pressure and femoral resistance were proportional to the amount of platelet aggregation, were accompanied by a rise (6-fold) in plasma serotonin levels downstream of the pump, but not in the aorta, and could be mimicked by serotonin-infusion into the leg. All hemodynamic changes were prevented or largely reduced by blockade of 5-hydroxytryptamine (5-HT)₂ receptors with pizotifen or ritanserin. The hypotension and femoral resistance decrease could also be prevented or abolished by inhibiting the production of nitric oxide (NO), an intermediate in 5-HT_2B receptor-induced vasodilation. When the extracorporeal blood was pumped into the aortic arch instead of the femoral artery, the hypotensive effect was similar and also NO dependent, but it was absent with venous return.

Conclusions— Pump perfusion with arterial return of the blood causes hypotension by endothelial NO-release, which in turn is triggered by serotonin from activated platelets.

Key Words: platelets • endothelium • receptors • vasodilation • stress

This article has been cited by other articles:

				M. Gritters, P. Borgdorff, M. P. C. Grooteman, M. Schoorl, M. Schoorl, P. C. M. Bartels, G.-J. Tangelder, and M. J. Nube Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility? Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2911 - 2917. [Abstract] [Full Text] [PDF]

				U. M. Fischer, R. Schindler, K. Brixius, U. Mehlhorn, and W. Bloch Extracorporeal Circulation Activates Endothelial Nitric Oxide Synthase in Erythrocytes Ann. Thorac. Surg., December 1, 2007; 84(6): 2000 - 2003. [Abstract] [Full Text] [PDF]

				P. Borgdorff, G. J. Tangelder, and W. J. Paulus Cyclooxygenase-2 Inhibitors Enhance Shear Stress-Induced Platelet Aggregation J. Am. Coll. Cardiol., August 15, 2006; 48(4): 817 - 823. [Abstract] [Full Text] [PDF]

				P. Borgdorff and G. J. Tangelder Pump-induced platelet aggregation with subsequent hypotension: Its mechanism and prevention with clopidogrel J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 813 - 821. [Abstract] [Full Text] [PDF]

				M. P. C. Grooteman and M. J. Nube Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter? Nephrol. Dial. Transplant., December 1, 2004; 19(12): 2965 - 2970. [Full Text] [PDF]

				V. Randriamboavonjy, J. Schrader, R. Busse, and I. Fleming Insulin Induces the Release of Vasodilator Compounds From Platelets by a Nitric Oxide-G Kinase-VAMP-3-dependent Pathway J. Exp. Med., February 2, 2004; 199(3): 347 - 356. [Abstract] [Full Text] [PDF]